Burosumab for CSHS
Early Phase 1
- Conditions
- Epidermal Nevus SyndromeCutaneous Skeletal Hypophosphatemia Syndrome (CSHS)
- Interventions
- First Posted Date
- 2019-06-21
- Last Posted Date
- 2022-03-07
- Lead Sponsor
- Laura Tosi
- Target Recruit Count
- 1
- Registration Number
- NCT03993821
- Locations
- 🇺🇸
Children's National Hospital, Washington, District of Columbia, United States
© Copyright 2025. All Rights Reserved by MedPath